Investment Thesis
cbdMD exhibits a deteriorating operational profile with flat revenue growth and negative operating cash flow, indicating a business in distress despite improving loss margins. While the debt-free balance sheet and strong gross margins (58.7%) provide a safety cushion, the company is burning ~$1.7M annually in free cash flow with only ~15 months of cash runway at current burn rates. Absent demonstrated revenue acceleration or path to operating profitability, the company faces significant execution risk.
Strengths
- Fortress balance sheet with zero long-term debt and 2.82x current ratio ensures near-term solvency
- Healthy 58.7% gross margin indicates product demand and pricing power despite revenue flatness
- Improving loss trajectory (net income up 53.4% YoY, EPS up 92.4%) suggests cost discipline or operational adjustments
Risks
- Negative free cash flow of -$1.7M with flat revenue growth signals unsustainable cash burn and insufficient runway without capital raise
- Operating losses of -$1.1M on $10.7M revenue indicate core business model is not yet viable at scale
- Zero revenue growth (0% YoY) in consumer discretionary sector suggests market headwinds, competitive pressure, or failed commercialization
Key Metrics to Watch
- Revenue growth rate - must inflect positive to 10%+ YoY to justify operations
- Operating cash flow - must turn positive within 2-3 quarters to validate path to breakeven
- Operating margin improvement - trend toward 0% or positive required to demonstrate unit economics viability
Financial Metrics
Revenue
10.7M
Net Income
-1.1M
EPS (Diluted)
$-1.09
Free Cash Flow
-1.7M
Total Assets
12.3M
Cash
2.6M
Profitability Ratios
Gross Margin
58.7%
Operating Margin
-10.2%
Net Margin
-10.1%
ROE
-11.6%
ROA
-8.8%
FCF Margin
-16.0%
Balance Sheet & Liquidity
Current Ratio
2.82x
Quick Ratio
1.59x
Debt/Equity
0.00x
Debt/Assets
24.2%
Interest Coverage
N/A
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-23T09:47:34.264982 |
Data as of: 2026-03-31 |
Powered by Claude AI